WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (32)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kane, M. D.
Right arrow Articles by Walker, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kane, M. D.
Right arrow Articles by Walker, L. C.

 Previous Article  |  Next Article 

The Journal of Neuroscience, May 15, 2000, 20(10):3606-3611

Evidence for Seeding of beta -Amyloid by Intracerebral Infusion of Alzheimer Brain Extracts in beta -Amyloid Precursor Protein-Transgenic Mice

Michael D. Kane1, William J. Lipinski1, Michael J. Callahan1, Feng Bian1, Robert A. Durham1, Roy D. Schwarz1, Alex E. Roher2, and Lary C. Walker1

1 Neuroscience Therapeutics, Parke-Davis Research, Division of Warner-Lambert, Ann Arbor, Michigan 48105, and 2 Haldeman Laboratory for Alzheimer's Disease Research, Sun Health Research Institute, Sun City, Arizona 85372

Many neurodegenerative diseases are associated with the abnormal sequestration of disease-specific proteins in the brain, but the events that initiate this process remain unclear. To determine whether the deposition of the beta -amyloid peptide (Abeta ), a key pathological feature of Alzheimer's disease (AD), can be induced in vivo, we infused dilute supernatants of autopsy-derived neocortical homogenates from Alzheimer's patients unilaterally into the hippocampus and neocortex of 3-month-old beta -amyloid precursor protein (beta APP)-transgenic mice. Up to 4 weeks after the infusion there was no Abeta -deposition in the brain; however, after 5 months, the AD-tissue-injected hemisphere of the transgenic mice had developed profuse Abeta -immunoreactive senile plaques and vascular deposits, some of which were birefringent with Congo Red. There was limited deposition of diffuse Abeta also in the brains of beta APP-transgenic mice infused with tissue from an age-matched, non-AD brain with mild beta -amyloidosis, but none in mice receiving extract from a young control case. Abeta deposits also were not found in either vehicle-injected or uninjected transgenic mice or in any nontransgenic mice. The results show that cerebral beta -amyloid can be seeded in vivo by a single inoculation of dilute AD brain extract, demonstrating a key pathogenic commonality between beta -amyloidosis and other neurodegenerative diseases involving abnormal protein polymerization. The paradigm can be used to clarify the conditions that initiate in vivo beta -amyloidogenesis in the brain and may yield a more authentic animal model of Alzheimer's disease and other neurodegenerative disorders.

Key words: Alzheimer's disease; amyloid; angiopathy; Abeta ; transgenic; prion; seeding; neurodegeneration; neuroinflammation; animal model; conformational disease


Copyright © 2000 Society for Neuroscience  0270-6474/00/20103606-06$05.00/0


This article has been cited by other articles:


Home page
Arch NeurolHome page
C. Soto and L. D. Estrada
Protein Misfolding and Neurodegeneration
Arch Neurol, February 1, 2008; 65(2): 184 - 189.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
M. Meyer-Luehmann, J. Coomaraswamy, T. Bolmont, S. Kaeser, C. Schaefer, E. Kilger, A. Neuenschwander, D. Abramowski, P. Frey, A. L. Jaton, et al.
Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host.
Science, September 22, 2006; 313(5794): 1781 - 1784.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. M. Robbins, R. A. Betensky, S. B. Domnitz, S. M. Purcell, M. Garcia-Alloza, C. Greenberg, G. W. Rebeck, B. T. Hyman, S. M. Greenberg, M. P. Frosch, et al.
Kinetics of Cerebral Amyloid Angiopathy Progression in a Transgenic Mouse Model of Alzheimer Disease
J. Neurosci., January 11, 2006; 26(2): 365 - 371.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. H. Mohajeri, M. A. Wollmer, and R. M. Nitsch
Abeta 42-induced Increase in Neprilysin Is Associated with Prevention of Amyloid Plaque Formation in Vivo
J. Biol. Chem., September 13, 2002; 277(38): 35460 - 35465.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-